Please login to the form below

Not currently logged in
Email:
Password:

off label

This page shows the latest off label news and features for those working in and with pharma, biotech and healthcare.

Stung by critics, J&J says antidepressant Spravato saves money

Stung by critics, J&J says antidepressant Spravato saves money

It is a single isomer form of ketamine, a low-cost anaesthetic, and ICER says the similarity between the two drugs “raises issues for all stakeholders about how to consider ... label prescription and coverage of a treatment that has not been as well

Latest news

More from news
Approximately 3 fully matching, plus 167 partially matching documents found.

Latest Intelligence

  • Rare disease trials Q&A Rare disease trials Q&A

    For studies using repurposed drugs, participation can be compromised by off- label usage outside a controlled research setting.

  • Five questions guiding the way to actual patient-centricity Five questions guiding the way to actual patient-centricity

    We worry about the effort real patients might make, the risks of social media, pharmacovigilance, off-label questions and a minefield of legal requirements.

  • Significant figures Significant figures

    Fast forward to last September and the company’s decision to put ALIS through phase III trials paid off, when it released late-stage results showing 29% of patients with NTM ... or less off-label as it’s not specifically indicated to treat the

  • Healthcare systems

  • The gold standard of scientific evidence The gold standard of scientific evidence

    More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics